STATCenter·
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Read at STAT →
Health · 1 sources covering this
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/d3a94ebcc2b5b0170eea6c4685d327421d1fd362" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?"></iframe>
